SomaLogic Raises $35 Million

SomaLogic Inc., a Boulder, Colo.-based developer of proteomics systems for medical diagnostics, has raised $35 million in Series A funding, according to a regulatory filing. Shareholders include Otsuka Pharmaceutical Co., Stronghold Capital, ProQuest Investments, Profundix LLC, MorrGold LLC and Quest Diagnostics Inc. www.somalogic.com